SuperworthCardiff Oncology market cap CRDF
Share price times shares outstanding: what the whole company sells for, since 2012.
- Today, Oct 23, 2026
- $70.6M
- Highest close in our data
- $774.3M
- Nov 2020
Cardiff Oncology is worth $70.6M at the close on Oct 23, 2026, at $0.91 a share.
That is down 52% over the last year and down 70% over five years.
Its highest close in our data was $774.3M in Nov 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $70.6M | $56.5M | $207.5M | −67% |
| 2025 | $213.5M | $136.4M | $284.7M | −3% |
| 2024 | $220.9M | $66.6M | $261.4M | +234% |
| 2023 | $66.1M | $44.7M | $88.5M | +6% |
| 2022 | $62.5M | $55.4M | $271.3M | −74% |
| 2021 | $237.7M | $199.4M | $647.1M | −63% |
| 2020 | $635.5M | $8.2M | $774.3M | +6312% |
| 2019 | $9.9M | $5.7M | $19.3M | −22% |
| 2018 | $12.6M | $3.6M | $22.1M | +7% |
| 2017 | $11.8M | $9.5M | $73.5M | −82% |
| 2016 | $64.3M | $64.3M | $186.4M | −60% |
| 2015 | $160.5M | $84.5M | $313.8M | +95% |
| 2014 | $82.4M | $56.7M | $127.4M | −26% |
| 2013 | $111.3M | $81.1M | $159.6M | +14% |
| 2012 | $98M | $27.1M | $103.2M | n/a |
Against its peers
Companies in Healthcare nearest Cardiff Oncology's size, closest first, today.
| Company | Market cap |
|---|---|
| CRDFCardiff Oncology | $70.6M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| APTAlpha Pro Tech | $56.7M |
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| ATNMActinium Pharmaceuticals | $47.8M |
| NEPHNephros | $38.3M |
| PDEXPro DEX | $199.3M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $83.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Cardiff Oncology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.